3570

antibody from Cell Signaling Technology, Inc

Targeting: CD44 CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

3570

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#3570, RRID:AB_2076465

Product name

CD44 (156-3C11) Mouse mAb

Antibody type

Monoclonal

Reactivity

Human

Host

Mouse

Storage

-20°C

References

Submitted references

Moesin is a glioma progression marker that induces proliferation and Wnt/β-catenin pathway activation via interaction with CD44.

Zhu X, Morales FC, Agarwal NK, Dogruluk T, Gagea M, Georgescu MM
Cancer research 2013 Feb 1;73(3):1142-55

---

Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

Zaytseva YY, Rychahou PG, Gulhati P, Elliott VA, Mustain WC, O'Connor K, Morris AJ, Sunkara M, Weiss HL, Lee EY, Evers BM
Cancer research 2012 Mar 15;72(6):1504-17

---

The use of multispectral imaging to distinguish reactive urothelium from neoplastic urothelium.

Gilbert CM, Parwani A
Journal of pathology informatics 2010 Oct 11;1:23

---

The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis.

Golubkov VS, Chekanov AV, Cieplak P, Aleshin AE, Chernov AV, Zhu W, Radichev IA, Zhang D, Dong PD, Strongin AY
The Journal of biological chemistry 2010 Nov 12;285(46):35740-9